The Jessica Sheu-Gruttadauria Lab
Research
The Sheu-Gruttadauria Lab asks fundamental questions about how the cell organizes gene expression. We are particularly interested in biomolecular condensates, a class of membraneless cellular compartments that concentrate factors involved in nearly every step of RNA metabolism from transcription to decay. Recent work suggests that condensates may form through biological phase transitions, creating microenvironments that exhibit distinctively dynamic biophysical features. However, defining the functional role of condensates and their unique biophysical properties remains exceptionally challenging. Meeting this gap is critical for human health, as condensates are often disrupted in degenerative diseases and cancers. The lab takes an interdisciplinary approach that spans structural biology, biochemistry, molecular and systems cell biology to mechanistically uncover how biomolecular condensates and their assembly features influence RNA metabolism in the cell— with the goal of better understanding the functional role of condensates in homeostasis and illuminating novel vulnerabilities in disease.
For more information about members, research, and lab values, please visit jsglab.org.
Publications Highlights
Sheu-Gruttadauria J†, Yan X, Stuurman N, Vale RD†, Floor SN†. “Nucleolar dynamics are determined by the ordered assembly of the ribosome.” bioRxiv. 2024 Oct 15:2023.09.26.559432. doi: 10.1101/2023.09.26.559432. PMID: 37808656. In revision. (†= Co-corresponding author)
Sheu-Gruttadauria J, MacRae IJ†. “Phase Transitions in the Assembly and Function of Human miRISC.” Cell. 2018 05 03; 173(4):946-957.e16. PMID: 29576456.
People
Jessica Sheu-Gruttadauria, PhD
Assistant Member
- The Sheu-Gruttadauria Lab investigates how biomolecular condensates and biological phase transitions shape gene expression in physiology and disease.
- BS Biochemistry, The University of Rochester
- PhD, The Scripps Research Institute
- Postdoc, University of California San Francisco
- sheugrj@mskcc.org
- Email Address
Members
Achievements
- Hanna H. Gray Fellow of the Howard Hughes Medical Institute (2019-2028)
- Damon Runyon Fellow (2019)
- American Heart Association Predoctoral Fellowship (2015-2018)
- Abrams Charitable Trust Award (2016)
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
General Opportunities
The lab is seeking postdoctoral candidates, research technicians, graduate students.
Get in Touch
-
Lab Head Email
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Jessica Sheu-Gruttadauria discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.